secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVANOS MEDICAL, INC. (AVNS)
CIK:        0001606498
Form:       8-K
Filed at:   2026-07-02T14:10:31+00:00
Accession:  0001606498-26-000085
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avanos receives all regulatory approvals for AIP acquisition; closing expected by July 27
--------------------------------------------------------------------------------

- All required regulatory approvals received for acquisition by American Industrial Partners affiliates.
- Transaction expected to close no later than July 27, 2026, subject to stockholder approval and other conditions.
- Special stockholder meeting to approve the merger scheduled for July 22, 2026.
- Avanos CEO David Pacitti and AIP Partner Joel Rotroff commented positively on the milestone.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000085/0001606498-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1606498/000160649826000085/avns-20260702.htm
  HTML page:      https://secwatch.observer/filing/0001606498-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer